Skip to main content
Antibiotice S.A. logo

Antibiotice S.A. — Investor Relations & Filings

Ticker · ATB ISIN · ROATBIACNOR9 LEI · 315700P5G4O1L6GLMS02 RO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2025-04-22 AGM Information
Country RO Romania
Listing RO ATB

About Antibiotice S.A.

https://www.antibiotice.ro/en/

Antibiotice S.A. is a pharmaceutical company specializing in the development and manufacturing of high-quality generic medicines for human use. The company is a significant producer of anti-infective drugs, with a portfolio that includes injectable penicillins like ampicillin and nafcillin, as well as the active pharmaceutical ingredient (API) Nystatin. It operates eight GMP-certified manufacturing lines and holds US Food and Drug Administration (FDA) approval for key products, underscoring its commitment to global quality standards. The company's mission is to make valuable medicines more accessible to patients, physicians, and pharmacists by providing affordable treatments. Its product range also extends to supplements and skincare products.

Recent filings

Filing Released Lang Actions
Raport curent de informare a investitorilor
AGM Information Classification · 1% confidence The document is a 'RAPORT CURENT' (Current Report) dated 22.04.2025 from Antibiotice SA. The core content is a formal notification that the company received a request from a shareholder (Infinity Capital Investments SA, holding 13.0301%) to convene both an Ordinary General Meeting (AGM) and an Extraordinary General Meeting (EGM) of Shareholders. The request details specific items for the agenda, including the election of the Board of Directors using cumulative voting and proposed amendments to the Articles of Incorporation regarding director/administrator termination clauses. This document is not the AGM presentation itself (AGM-R), nor is it a full Annual Report (10-K) or an Interim Report (IR). It is an official regulatory filing announcing a significant corporate governance event—a shareholder request to call a meeting to vote on key structural and governance matters. Since the document is a formal regulatory disclosure about a pending shareholder meeting and governance changes, it aligns best with the general category for corporate governance/shareholder meeting related announcements, which often fall under Regulatory Filings (RNS) or, more specifically, documents related to the meeting process itself. Given the content is the *request* to convene the meeting, and it is a formal current report, it is a regulatory filing. However, the subject matter is explicitly about convening the General Assembly of Shareholders (Adunare Generală a Acționarilor). The closest specific category related to shareholder meetings and voting is 'AGM-R' (AGM Information) or 'PSI' (Proxy Solicitation & Information Statement). Since this is the *request* to call the meeting, and not the final proxy materials or the meeting itself, 'RNS' (Regulatory Filings) is a strong candidate as a general disclosure. However, because the entire document revolves around the mechanics and agenda of calling the General Assembly, and the request is being made by a shareholder, it is a precursor to the AGM. In many filing systems, requests or notices related to the calling of the AGM are classified under AGM-related codes. Given the options, and the focus on convening the General Assembly, 'AGM-R' (AGM Information) is the most contextually relevant classification for a document initiating the AGM process, even though it's a request rather than the final materials. If 'RPA' (Report Publication Announcement) were used, it would imply this document announces the publication of *another* report, which is not the primary function here. Therefore, classifying it as an AGM-related filing is appropriate.
2025-04-22 Romanian
Raport curent de informare a investitorilor
Notice of Dividend Amount Classification · 1% confidence The document explicitly details the 'Repartizarea profitului net pe anul 2024' (Net profit distribution for 2024) and the 'fixarea dividendului brut pe actiune' (setting of the gross dividend per share). It provides a detailed breakdown of how the net profit (102,202,828 lei) is allocated to legal reserves, tax facilities, and specifically, dividends (13,800,876 lei), including the final gross dividend amount per share (0.020557268 lei/share) and the payment date. This content is a direct announcement of dividend amounts and related profit allocation decisions, which aligns perfectly with the definition of 'Notice of Dividend Amount' (DIV). It is not a full annual report (10-K), an earnings release (ER) focusing only on highlights, or a general regulatory filing (RNS).
2025-03-13 Romanian
Convocarea adunarii generale a actionarilor - RC11
AGM Information Classification · 1% confidence The document is titled "RAPORT CURENT" (Current Report) and its main content is a "CONVOCAREA Adunării Generale Ordinare a Acționarilor" (CONVOCATION of the Ordinary General Meeting of Shareholders). It details the date, time, location, and the specific agenda items for the upcoming shareholder meeting (e.g., approving 2024 reports, approving dividend distribution, approving remuneration report). This document serves to formally notify shareholders about the meeting and solicit their participation/votes, which aligns perfectly with the definition of materials shared during an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2025-03-13 Romanian
Raport curent de informare a investitorilor
Regulatory Filings Classification · 1% confidence The document is titled "RAPORT CURENT" (Current Report) and is dated 07.03.2025. It details a specific, non-financial event: a visit from the Vice-President of IBM Research to discuss integrating advanced technologies (quantum computing, AI) into Antibiotice Iași's R&D center. This type of announcement, detailing strategic operational or partnership developments that are material to the company but do not fit standard financial reports (10-K, IR, ER), typically falls under general regulatory announcements or specific corporate governance/strategic updates. Since it is not a standard financial report, a dividend notice, a director's dealing, or a formal AGM/Proxy material, it is best classified as a general Regulatory Filing (RNS) or potentially a strategic update. Given the nature of reporting material corporate events that aren't strictly financial results or capital changes, RNS is the most appropriate general category for significant, non-standard corporate news releases in this context. The length (3735 chars) is substantial enough to be the report itself, not just an announcement of a report.
2025-03-07 Romanian
Raport curent de informare a investitorilor
Report Publication Announcement Classification · 1% confidence The document is a formal communication, written in Romanian, detailing a revised schedule ('modificarea calendarului de comunicare financiară') for the company's financial events throughout 2025. Key scheduled events include the presentation of annual financial results, the Annual General Shareholders' Meeting ('Adunarea Generala a Acționarilor'), the presentation of the Annual Report ('Prezentarea Raportului anual'), quarterly report presentations, and investor meetings. Since this document is announcing the timing and dates of future report publications and shareholder meetings, it fits the definition of announcing the release of reports rather than being the report itself. This aligns best with the Report Publication Announcement (RPA) code, as it explicitly publishes a schedule for future report releases.
2025-03-07 Romanian
REZULTATE FINANCIARE PRELIMINARE
Investor Presentation Classification · 1% confidence The document is titled "Prezentarea rezultatelor financiare preliminate anul 2024" (Presentation of preliminary financial results for 2024) and contains detailed tables showing 'Situatia rezultatului global' (Global result situation) with comparative figures for 31.12.2024 (preliminary, unaudited) versus 31.12.2023 (audited). It explicitly details Revenue, Expenses, Gross Profit, and Net Profit, along with management commentary on business performance, market analysis, and export results for the full year 2024. This structure strongly indicates a comprehensive annual financial disclosure, even if labeled 'preliminary'. Since the document is extensive (48,768 characters) and contains the full financial statements/results rather than just an announcement of their release, it should be classified as an Annual Report (10-K equivalent for comprehensive annual data), or potentially an Interim/Quarterly Report (IR) if the context implied it was only for a partial year, but the dates (31.12.2024) confirm it covers the full fiscal year. Given the comprehensive nature covering the entire year's performance, 10-K is the most appropriate classification among the options for a full-year financial report.
2025-02-26 Romanian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.